2026 ICD-10-CM Diagnosis Code T46.8X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T46.8X4S is a billable ICD-10-CM diagnosis code for poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.
Code Identity
Code Classification
Present on Admission (POA)Billing
T46.8X4S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Coding GuidelinesGuidance
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Polidocanol
an alkyl polyglycol ether of lauryl alcohol, chemically defined as an alcohol ethoxylate having an average alkyl chain of 12–14 carbon atoms, and an ethylene oxide chain of 9 ethylene oxide units. it is used as a detergent, and medically as a local anesthetic, and as a sclerosing agent for the treatment of esophageal and gastric varices and varicose veins.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Antivaricose drug | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Ethanolamine oleate | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Monoethanolamine | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Monoethanolamine::oleate | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Polidocanol | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Sclerosing agent | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Sotradecol | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Varicose reduction drug | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
| Venous sclerosing drug NEC | T46.8X1 | T46.8X2 | T46.8X3 | T46.8X4 | T46.8X5 | T46.8X6 |
Patient EducationClinical
Poisoning
A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T46.8X4S to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T46.8X4SOverview
Is T46.8X4S a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character S in T46.8X4S mean?
The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by antivaricose drugs, including sclerosing agents, undetermined itself has resolved, not the original event.
What MS-DRG does T46.8X4S group to?
When poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.
Is T46.8X4S exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela on inpatient claims.
What is the ICD-9 equivalent of T46.8X4S?
Under the General Equivalence Mappings, poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E989 (late eff inj-undet circ). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
